PEGylation Services

• PEGylation of Amino Acids
• PEGylation of Nanocarriers
• PEGylation of Peptides and Proteins
• PEGylation of Small Molecule Drugs
• PEGylation of Lipids
• PEGylation of Nucleic Acids
• PEGylation of Antibodies
• PEGylation of Carbohydrates
• PEGylation of Biotin
• PEGylation of Enzymes
• PEGylation of Cytokines

• 

  PEGylation of Small Molecule Drugs

• 

  PEGylation of Peptides and Proteins

• 

  PEGylation of Nanocarriers

PEGylation is a chemical process to couple polyethylene glycol (PEG) polymer chains to macromolecules, such as proteins, drugs or vesicles. By increasing the volume of drug molecules, it can effectively extend its half-life in the body, while shielding its immune sites to significantly reduce immunogenicity. PEGylation is one of the most effective long-acting protein preparation technology recognized internationally. As a leading biotechnology services supplier, BOC Sciences has advanced skills that can offer customized synthesis pathways of various PEGylated conjugates, such as peptides/proteins, oligonucleotides, small molecule drugs, as well as different types of nanocarriers for customers to meet their unique requirements.

PEGylation services include:

In order to accomplish PEGylation, a variety of chemical modifications are utilized to prepare an active PEG derivative with a reactive functional group at one or both termini. Further the use of reactive functional group mainly depends on the substrate to be conjugated to PEG. Our PEGylation techniques can be roughly divided into the following three parts:

PEGylation of Peptides and Proteins

Among the 20 types of common amino acids that make up proteins, only those with polar side chain groups can be chemically modified. The activated PEG realizes the coupling through chemical reaction with the amino acid residues on the peptide or protein molecules. The active groups on these amino acid residues are mostly nucleophilic, and their activity usually decreases in the following order: sulfhydryl > α-amino > ɛ-amino > carboxy > hydroxyl. With our expertise as a leader in the field of PEGylation, BOC Sciences can offer you great services to help you design desired PEGylated proteins

PEGylation of Nanocarriers

The addition of PEG to the nanocarrier surface can reduce many of challenges, such as reducing reticuloendothelial system (RES) uptake and increasing circulation time versus uncoated counterparts. Due to difference in the chemical make-up, strategies used for PEGylation of nanocarriers can be broadly classified under the titles of polymeric nanoparticles, liposomes, micelles and inorganic nanoparticles. Our expertise in polymer chemistry and surface science can provide you practice advices, help you design the experiment, and prepare PEG functionalized products for your needs.

PEGylation of Small Molecule Drugs

To date, many organic small molecule drugs have gradually adopted PEGylation technology and certain progress has been made. The conjugated drugs also has good biocompatibility, can be dissolved in the tissue fluid in the body, and can be quickly excreted from the body without any toxic side effects. Pease contact us for more details of our preclinical PEGylation service. BOC Sciences's dedicated and experienced PEGylation group will offer you the most optimal solution for your project.

PEGylation Service Model 1

PEGylation service model 2

Why Us?

PEGylation Service Process

Reference

1. Harris, J. M.; Chess, R. B., Effect of PEGylation on pharmaceuticals. Nature reviews Drug discovery 2003, 2 (3), 214-221.
2. Kolate, A.; Baradia, D.; et al. PEG - a versatile conjugating ligand for drugs and drug delivery systems. Journal of controlled release : official journal of the Controlled Release Society 2014, 192, 67-81.
3. Pasut, G.; Veronese, F. M., State of the art in PEGylation: the great versatility achieved after forty years of research. Journal of controlled release : official journal of the Controlled Release Society 2012, 161 (2), 461-72.